Skip to Content
 

News: Breast Cancer

Cancer Center investigators awarded Komen grants

Friday, October 12th, 2018

Vanderbilt-Ingram Cancer Center (VICC) investigators have received financial support from Susan G. Komen for breast cancer research.

VICC’s Levy to lead Rush University Cancer Center

Thursday, October 4th, 2018

Mia Levy, MD, PhD, director of Cancer Health Informatics and Strategy at Vanderbilt-Ingram Cancer Center (VICC) and Ingram Associate Professor of Cancer Research, has been named director of Rush University Cancer Center and Systems Vice President for Cancer Service at Rush University Medical Center in Chicago.

Cochran celebrates cancer treatment’s end in style

Thursday, October 4th, 2018

Singer Anita Cochran had famous friends in the room when she celebrated her last cancer treatment, but the person with her who mattered the most was her 89-year-old father.

Team identifies new gene candidates for breast cancer risk

Monday, July 2nd, 2018

A new study has identified 48 candidate susceptibility genes for breast cancer risk, including 14 genes at loci (chromosome regions) not yet reported for breast cancer.

New breast cancer targets

Friday, May 4th, 2018

Using four large-scale data sets from normal and cancerous breast tissue samples, Vanderbilt researchers have identified 101 candidate breast cancer susceptibility genes with variant-associated gene expression changes.

New VU Breast Health Cool Springs clinic makes debut

Thursday, May 3rd, 2018

The VU Breast Health Cool Springs clinic, located at 324 Cool Springs Blvd., Suite B, Franklin, provides a range of medical services for individuals at high risk for developing breast cancer.

VICC breast cancer leaders named Komen Scholars

Friday, April 13th, 2018

Ingrid Mayer, MD, MSCI, Ingram Professor of Cancer Research and leader of the Breast Cancer Research Program, has been named a Komen Scholar for her leadership in breast cancer research. She is joined by Wayne Dornan, PhD, a patient research advocate at VICC, who will serve on the Advocates in Science Steering Committee for Susan G. Komen.

Study seeks to boost breast tumor immune response

Thursday, February 8th, 2018

Targeting specific molecules in breast tumors, called methylating agents, can turn up the immune response, potentially making tumors responsive to immunotherapy, suggests a new study published in Nature Communications.

Macara named ‘Pink Tie Guy’ for Komen breast cancer research

Thursday, January 11th, 2018

Ian Macara, PhD, Louise B. McGavock Professor and Chair of Cell and Developmental Biology and co-leader of the Signal Transduction and Chemical Biology Research Program at Vanderbilt-Ingram Cancer Center (VICC), has been named one of the Pink Tie Guys for the Susan G. Komen Central Tennessee organization.

Mathis strives to make her cancer journey meaningful

Thursday, November 9th, 2017

Amanda Mathis went from being a patient at Vanderbilt-Ingram Cancer Center to becoming a member of the cancer center’s Board of Overseers.

Next Page »